Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Plos One
|
July 7, 2021
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
Iliana K Kerzeli, Martin Lord, Milena Doroszko, et al.
Urologia Internationalis
|
December 16, 2014
Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus
Bernd J Schmitz-Dräger, Michael Droller, Vinata B Lokeshwar, et al.
Scientific Reports
|
July 16, 2022
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
Hideki Furuya, Yuka Sasaki, Runpu Chen, et al.
World Journal of Urology
|
March 13, 2021
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer
David D'Andrea, Francesco Soria, Anne J Grotenhuis, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Plos One
|
July 7, 2021
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
Iliana K Kerzeli, Martin Lord, Milena Doroszko, et al.
Urologia Internationalis
|
December 16, 2014
Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus
Bernd J Schmitz-Dräger, Michael Droller, Vinata B Lokeshwar, et al.
Scientific Reports
|
July 16, 2022
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
Hideki Furuya, Yuka Sasaki, Runpu Chen, et al.
World Journal of Urology
|
March 13, 2021
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer
David D'Andrea, Francesco Soria, Anne J Grotenhuis, et al.
Page
of 2